Role of Aspartate-1 in Cu(II) Binding to the Amyloid-β Peptide of Alzheimer's Disease
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Considerable effort is being directed at unraveling the molecular mechanisms of Alzheimer's disease (AD), including the participation of metal ions. The extracellular proteinaceous plaques associated with AD are composed predominantly of the amyloid-beta (Aβ) peptide, which has been shown to bind copper. Because coordination environment is an important determinant of copper reactivity, work to establish the copper binding site in Aβ is central to understanding copper's role in AD. A major controversy centers on the coordination environment of Cu(II) when bound to Aβ. We have shown previously that tyrosine is not the O-atom donor to Cu(II) and that N-terminal deletions to the Aβ peptide disrupt the native Cu(II) binding site [Karr, J. W.; Akintoye, H.; Kaupp, L. J.; Szalai, V. A. Biochemistry, 2005, 44, 5478−5487]. Here, we present low-temperature electron paramagnetic resonance (EPR) spectra of Cu(II) bound to N-terminal mutants of Aβ16 as a means to assess the role these amino acids play in creating the Cu(II) binding site at pH 7.2. Mutation of glutamate-3 to glutamine produces no effect on the EPR spectrum of Cu(II) bound to the Aβ peptide, indicating that this residue is not involved in Cu(II) binding. In contrast, mutation of aspartate-1 to asparagine produces a spectrum with two components. The spectrum of the first component is identical to that observed for wild-type peptide in the presence of Cu(II) at pH 7.2. The second component has very different EPR parameters ( A ∥ = 156 ± 1 G and g ∥ = 2.226). Our data are consistent with a model in which the carboxylate of aspartate-1 creates the native binding site through hydrogen-bonding interactions rather than through direct ligation to Cu(II) in Aβ. Our results clearly influence research conducted on copper and Aβ, but our model also impacts work on the interaction of copper with α-synuclein (Parkinson's disease) and prion proteins involved in other neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gaggelli, E., Kozlowski, H., Valensin, D., & Valensin, G. (2006) · Chemical Reviews · doi:10.1021/cr040410w · Cited by 1,729
Metals and Alzheimer's disease
Adlard, P. A., & Bush, A. I. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-102-303 · Cited by 324
Cited by
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 581
Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-β peptide
Faller, P., & Hureau, C. (2009) · Dalton Trans. · doi:10.1039/b813398k · Cited by 530
Metallostasis in Alzheimer's disease
Ayton, S., Lei, P., & Bush, A. I. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.558 · Cited by 352
Copper and Oxidative Stress in the Pathogenesis of Alzheimer’s Disease
Eskici, G., & Axelsen, P. H. (2012) · Biochemistry · doi:10.1021/bi3006169 · Cited by 290
Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics
Duce, J. A., & Bush, A. I. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.003 · Cited by 283
The role of metallobiology and amyloid-β peptides in Alzheimer's disease
Roberts, B. R., Ryan, T. M., Bush, A. I., Masters, C. L., & Duce, J. A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07500.x · Cited by 266
Cheignon, C., Jones, M., Atrián-Blasco, E., Kieffer, I., Faller, P., Collin, F., & Hureau, C. (2017) · Chemical Science · doi:10.1039/c7sc00809k · Cited by 132
Metadata
- Authors
- Karr, J. W., & Szalai, V. A.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2007-03-13
- Volume
- 129
- Issue
- 13
- Pages
- 3796-3797
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W2002416269
- Cited by
- 105
- References
- 2
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.